Start TB Patients on ART and Retain on Treatment (START Study) (START)
Start TB Patients on ART and Retain on Treatment: Combination Intervention Package to Enhance Antiretroviral Therapy Uptake and Retention During TB Treatment in Lesotho
Sponsor: Columbia University
This NA trial investigates HIV and Tuberculosis and is currently completed. Columbia University leads this study, which shows 9 recorded versions since 2013 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
▶ Show 4 earlier versions
-
Sep 2019 — Aug 2020 [monthly]
Active Not Recruiting NA
-
May 2019 — Sep 2019 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Jun 2018 — May 2019 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Apr 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Columbia University
- United States Agency for International Development (USAID)
For direct contact, visit the study record on ClinicalTrials.gov .